Mauna Kea Technologies S.A.

PAR • Healthcare • Medical Devices • Quote as of 10/30/2026

Company Profile

IndustryMedical Devices

SectorHealthcare

ExchangePAR

Market Capitalization20.42 mln

Float119 mln

Earnings Date04/24/2025

EPS

0.16

Marginal

P / E

0.61

Anomalous

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

3.73

Highly suspicious

Relative Strength

4 / 100

Severely lagging

Pre-Tax Margin

159%

Exceptional margin

Business Description

Founded in Paris in 2000, Mauna Kea Technologies SA develops and markets medical imaging technology across North America, Europe, the Middle East, Africa, and Asia. Its flagship product, Cellvizio, gives doctors a live, cellular-level view inside the body, supporting real-time decision-making during procedures related to digestive, respiratory, and urinary conditions.

Key Fundamentals

EPS0.16

P/E0.61

ROE-158

RPS0.06

ROIC-22.71

ROA97.54

Interest Cover-4.16

EBITDA, mln15.51

EV / EBITDA1.90

EV / EBIT2.06

Revenue, mln8.22

EV / Revenue3.58

Quote Details

Last 0.097

Change 0.0006 (0.62%)

Open 0.096

Volume 291,172

Turnover 28,244

Average Volume 590,228

Financial Ratios

Pre-Tax Profit Margin159

Current Ratio2.07

Price / Sales1.37

Financial Strength

Altman Z-Score5.58

Piotroski F-Score 4 / 9

Beneish M-Score3.73

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	1.46%	69 / 100
1 Month	-30.71%	2 / 100
2 Months	-36.27%	4 / 100
6 Months	-44.63%	6 / 100
1 Year	-1.12%	42 / 100